About Me |
|---|
As a dedicated teaching professional looking to contribute my skills in a organization which offers a genuine opportunity to learn and grow.
|
- Novel Drug Delivery System
- 16 Year
- Periodontal Drug Delivery System
- Formulation Development
- Pharmacokinetics Study
- Targeted Drug Delivery System
- Bioavailability improvement
Research Fields
Recent Publications (International Journals)
| Sl. No. | Title | Issuer |
|---|
Academic Honors & Awards
Formulation, Characterization and In Vitro Evalution of Gabapentin Floating Microspheres
Novel Periodontal Pocket Drug Delivery Systems for the Treatment of Periodontitis
Design, Characterization and Clinical Evaluation of Curcumin Dental Film for the Treatment of Periodontitis
Clinical features and laboratory diagnosis tool for emerging corona virus (COVID-19): A review
Design and in vitro evaluation of curcumin dental films for the treatment of periodontitis. Asian Journal of Pharmaceutics
Design and Characterization of Lamivudine Controlled Release Matrix Tablets
Design and Characterization of Ofloxacin and Dexamethasone Ocular Inserts Using Combination of Hydrophobic and Hydrophilic Polymers
Overview of Myasthenia Gravis Subgroups and its influence on Pregnancy and their Treatment Advances
Antibodies that attack the neuromuscular junction induce myasthenia gravis, an immunological illness. Such antibodies assault and degrade postsynaptic molecules in by binding to the postsynaptic muscular end-plate. As a consequence, signal transduction is disrupted, resulting in muscular weakness and fatigability. Developments in our knowledge of the immunological mechanisms that cause myasthenia gravis have paved the way for the development of new targeted immunity treatments. The majority of myasthenia gravis sufferers have a well-managed condition with just minor to moderate symptoms. The goal must be to create more targeted therapies that reduce or enhance tolerance to the well-known and particular autoimmune reactions that result in autoantibody formation and muscular weakening. Several drugs widely used in obstetrics can aggravate the condition. The impact of maternity on myasthenia varies greatly from one woman to the next, as well as from one pregnancy to the next within the same woman. Acetylcholine esterase inhibitors, corticosteroids, and other immunosuppressants, as well as proper rest, are the most common therapy. Intrauterine antibody exposure can cause in utero or neonatal effects in newborns, which are usually temporary. This review focuses on myasthenia gravis subgroups and treatment breakthroughs, as well as the influence of myasthenia gravis on pregnancy and its management.
Herb for the management of diabetes mellitus: A comprehensive with special reference to preclinical , clinical trial and its proposed mechanism
In recent times, herbal medicines have experienced exponential expansion in both developing and developed nations due to its natural origin and lack of adverse effects. To gather information regarding herbal plants used to treat diabetes mellitus, a systematic review was undertaken. The aim of this article is to review evidences from preclinical and clinical trials and the proposed mechanism of the herbal drugs in diabetes mellitus. In this review, the literature survey mainly focused on scientific papers published in recent years. The search strategy involved the interrelated keywords like Diabetes mellitus, Herbs, Hyperglycemia et.c. Electronic databases used were Scopus, Web of Science, PubMed, Elsevier etc. A large number of clinical and preclinical study has been presented for evaluating the mechanism of anti-hyperglycaemic effect of herbal drugs in diabetes mellitus. Through clinical and preclinical research as well as an analysis of their mechanism of action, the current review offers preliminary evidence for possible antidiabetic benefits of herbal medicines
In recent times, herbal medicines have experienced exponential expansion in both developing and developed nations due to its natural origin and lack of adverse effects. To gather information regarding herbal plants used to treat diabetes mellitus, a systematic review was undertaken. The aim of this article is to review evidences from preclinical and clinical trials and the proposed mechanism of the herbal drugs in diabetes mellitus. In this review, the literature survey mainly focused on scientific papers published in recent years. The search strategy involved the interrelated keywords like Diabetes mellitus, Herbs, Hyperglycemia et.c. Electronic databases used were Scopus, Web of Science, PubMed, Elsevier etc. A large number of clinical and preclinical study has been presented for evaluating the mechanism of anti-hyperglycaemic effect of herbal drugs in diabetes mellitus. Through clinical and preclinical research as well as an analysis of their mechanism of action, the current review offers preliminary evidence for possible antidiabetic benefits of herbal medicines
Glimepiride Based Solid Dispersion Composition for Type-2 Diabetes
A system and composition for treating and preventing oxalate related conditions
AN ARTIFICIAL INTELLIGENCE BASED 3D PRINTED MEDICINES FOR EFFECTIVE TREATMENT OF PATIENTS AND METHOD THEREOF
The present invention discloses an Artificial Intelligence based 3D printed medicines for effective treatment of patients and method thereof. In the present invention, obtaining prescription dosage guidelines, creating a customised dose in accordance with the prescription dose guidelines, and building the customised dose using a 3D printer. Furthermore, including a signal connecting unit to allow communication between the 3D printer and the container holding the medication component, by adding binder to powder material to create increasingly bound bodies—which correspond to sectional data blocks made by slicing an original item with parallel planes—a three-dimensional product is created.
Novel nano formulations-based drugs for enhanced bioavailability
The present invention reveals novel highly bioavailable, water soluble, sustained release nanoformulation(s) comprising unique proportions of hydrophobic plant-derived compound(s) in an
emulsifier phase and an aqueous phase to achieve the desired sustained release over a time period of at least 24 hours and possibly longer. The procedure for preparing such unique watersoluble, highly bioavailable, and sustained-release nanoformulation thereof is also disclosed by the present invention.